FINANCIALS

DNA Ginkgo Bioworks Holdings Inc 1830214

Income Statement
Revenue	dna-20240930	89,046,000
Net Income	dna-20240930	-56,403,000
Profit Margin		-63.34%

Balance Sheet
Current Assets	662,480,000
Assets	1,480,883,000
Current Liabilities	114,427,000
Liabilities	682,940,000
Equity	797,943,000
Shares Out	43,103,000

Cash Flow Statement
Operating Cash Flow	-277,150,000
Investing Cash Flow	-49,151,000

Market Analysis
Market Cap	367,501,824
Price	10.83
BVPS	18.51
PB	0.57
EPS	-18.03
PS	1.03
FCF	-326,301,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view DNA documents filed with the SEC.

DNA Filings Clear

View A List of Tickers